chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had a rash that began on August 4, 2010 that covered both arms and both legs and there were a few spots on his belly and back. The rash look like red hives. They bumps were elevated. I took him to the pediatrican's office for the first of three total visits that same day. The doctor's office told me to treat patient with Benadryl. The second day of the rash patient spiked a fever of 102 and I took him to the doctor's office on 8/6/2010. On day three of the rash it began to spend all over his entire body including in his head and ears. I took him for the third time on 8/8/2010. The consensus of the 3 office visits was undetermined. The nurse on the first visit was convinced that it was a reaction to the chicken pox vaccine. The doctor's never came to a conclusion. One said insect bites which I strongly disagreed with and another same that it was a reaction that was undetermined and the last was unsure...I strongly feel it was a reaction to the chicken pox vaccine.
1st dose vaccine 1/30/2021; fall of unknown etiology at home on 2/1/21; went to urgent care 2/1/21 for back pain, sent to ED same day for eval; admitted to hospital on 2/1/21 from ED for T12 compression fracture.
Hives; wheezing; fever; aches; fatigue; headache; nausea; Product use for unapproved combination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Sep2022 at 13:45 as dose 4 (booster), single (Lot number: GJ6742) at the age of 46 years intramuscular, in right arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 29Sep2022 as dose 1, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "Chronic Asthma" (unspecified if ongoing); "Allergies" (unspecified if ongoing); "Alopecia" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: Sulfonamide Antibiotics" (unspecified if ongoing); "Known allergies: Tree nuts" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; ATENOLOL; CALAN [VERAPAMIL HYDROCHLORIDE]. Vaccination history included: Covid-19 vaccine (DOSE 1,SINGLE, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2,SINGLE, MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3,SINGLE, MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 29Sep2022, outcome "unknown", described as "Product use for unapproved combination"; URTICARIA (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering", described as "Hives"; PAIN (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering", described as "aches"; FATIGUE (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering"; PYREXIA (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering", described as "fever"; HEADACHE (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering"; NAUSEA (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering"; WHEEZING (non-serious) with onset 29Sep2022 at 21:00, outcome "recovering". Therapeutic measures were taken as a result of urticaria, wheezing, pyrexia, pain, fatigue, headache, nausea.  Additional information: The patient did not receive any other vaccine in four weeks. The patient did not have covid prior vaccination and patient had not tested for covid post vaccination. The patient received Benadryl, Albuterol Inhaler, Ice pack, Rest, Advil as treatment for the events.
pyrexia; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (pyrexia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (pyrexia). At the time of the report, PYREXIA (pyrexia) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102 Fahrenheit Degree.         No concomitant medication were provided by the reporter  No treatment medication were provided by the reporter   This case was linked to MOD-2021-306289 (Patient Link).
Pt. came to pharmacy 10/8/15 in the morning with arm (left) bruised and a little swollen. I directed her to her dr. and told her we could would follow up (+) report incident.
Pt cried considerably after vaccines. After several hours, she developed swelling of arms, feet and face. Also, she developed fever. She was taken to the ER about 7pm. There she got IM Benadryl. There was no respiratory involvement. Swelling and urticaria improved so sent home (on oral Benadryl) and came to my office the following day 05/31/02. She is fine except for minimal ower eye had swelling.
We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1713 and MA2009-1715 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
pt recv vax 1MAY97 & 3MAY97 pt devel a little mark like a mosquito bite;area was swollen & it had a rash;4MAY97 pt devel another mark & subsequently & devel one on rt hand;
received Shingrix shot #1 on 09-Dec-2020  / has not yet received dose 2; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 9th December 2020, intramuscularly in the left deltoid).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional case details were reported as follows: The patient reported case for himself. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not yet receive dose 2 of vaccine, which led to incomplete course of vaccination. The reporter did not have lot number available but did provide the pharmacy contact information. The VAERS details were reported for 1st dose. In March 2021, the patient received 1st and 2nd dose of Covid Moderna shots. The reporter did not consent to follow up.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ALLERGIC REACTION, INIT  9/24/2022 & 9/26/2022  --  RECURRENCE OF SAME SYMPTOMS
Site: Pain at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Felt \"unwell\" for 4 days-Medium, Error: Incorrect Reconstitution, Additional Details: Patient states that his right arm feels weaker than normal and is impacting him at this job.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 09-DEC-2016, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries. In December 2016, after and despite being inoculated with the ZOSTAVAX, the patient was diagnosed with shingles and/or other zoster-related injuries and suffered serious physical, emotional and economic damages as a result of patient's injuries. On or about 27-DEC-2016, the patient was treated for shingles. The reporter considered adverse events to be related to ZOSTAVAX. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care - for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
redness; red rash at the neck, face ears and injection site; arm tender; red rash at injection site; arm itchy; arm felt warm touch; injection site redness; diarrhea; fatigue; headache; nausea; body ache; This spontaneous case was reported by a nurse and describes the occurrence of   in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.   This case was linked to MOD-2021-004726 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Non significant Follow up; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Flu with no fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu with no fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu with no fever). At the time of the report, INFLUENZA (Flu with no fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned.  The patient was concerned if she should get the second dose if she still has the flu.  No treatment details were reported.
neuropathy; arthritis; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient, self-reported). A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry dates were not provided), via an unspecified route of administration on an unspecified date, as SINGLE DOSE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that patient wants to know that if she supposed to take Tylenol after having first shot of Vaccine. On an unspecified patient experienced neuropathy and arthritis. Patient took the medication Tylenol after the first dose. The outcome of the events was unknown.     Information of lot/batch number has been requested.
Patient complained of full body aches/chills and skin sensitivity which lasted a few days after receiving the vaccine.
arm at injection site was much more sore than previous injections; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in the left arm, administration date 22Mar2021 (Lot number: EP7534) at the age of 40 years as dose 1, single; and administered in the left arm, administration date 15Apr2021 (Lot number: EN0612) as dose 2, single both for COVID-19 immunisation. Relevant medical history included: "diabetes" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "ADHD" (unspecified if ongoing). Concomitant medications included: CELEXA [CELECOXIB]; TRULICITY; SYNJARDY; BUPROPION. Past drug history included: Codine, reactions: "known allergies: Codine". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "arm at injection site was much more sore than previous injections".  Additional information: The patient received the third dose of BNT162B2 and reported that her arm at injection site was much more sore than previous injections.  No follow-up attempts are possible. No further information is expected.
Approximately 3 weeks after 1st vaccine, on March 14, 2021, I developed a film over my right eye and experienced jagged multi colored lines. Experienced this every few days for anywhere from 15 minutes to 1 hour in length. Again 3 weeks after my second vaccine, I woke up with the same eye problem which has been constant now for 1 week.  I am unable to see  clearly out of my right eye. This is still ongoing and my retinal specialist believes a blood clot may have traveled to my eye and burst causing this problem.
Patient reported urticaria and pruritus that developed 30 minutes after vaccine administration. The reaction was bilateral along the length of arms and possibly some involvement on trunk/back. The rash resolved within 24 hours. Patient reports 3 unresolved spots remaining on skin.
lips and face swelled; lips and face swelled; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (lips and face swelled) and LIP SWELLING (lips and face swelled) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032LZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SWELLING FACE (lips and face swelled) and LIP SWELLING (lips and face swelled). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, SWELLING FACE (lips and face swelled) and LIP SWELLING (lips and face swelled) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient confirms taking 2 doses of Benadryl within a 24-hour period.
Information has been received from a physician's nurse concerning a 15 year old female who on 27 Sep 2006 was vaccinated intramuscularly with HPV vaccine (lot # 653937/0637F). On 28 Sept 2006 the patient experienced nausea, fever and soreness at the injection site. Unspecified medical attention was sought. At the time of this report, the outcome of the events was unknown.
Nurse administering it seemed to plunge the syringe before it was in my arm and some leaked out; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and nurse administering it seemed to plunge the syringe before it was in my arm and some leaked out.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, on the same day at the onset of the event, the patient received a dose of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date while the vaccine was being administered, the patient reported the nurse administering it seemed to plunge the syringe before it was in her arm and some leaked out. Enough vaccine spilled out that the nurse had to dry the patient's arm from the drip. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The event, nurse administering it seemed to plunge the syringe before it was in my arm and some leaked out, was considered resolved on an unknown date.; Reporter's Comments: This report refers to a case of incorrect dose administered for mRNA-1273.  There were no reported adverse events associated with this case.
On 2/26/21 I woke up with a fever and vomiting. This continued for several days, but the fever went away after 2 days. On 3/3/21, I went to the ER with severe right side pain. They ran a series of tests, determining that I had pancreatitis, but were unclear as to why because I do not drink alcohol and had my gallbladder removed in 2011. They admitted me to the hospital and my lipase level continued to rise each day until it was around 850. I spent the following 8 days (3/3/21-3/11/21) in the hospital.
A bruise lasting almost 2 weeks and a large red ring around the injection site showed up about a week after getting my first injdction
Pt recvd yellow fever vax in rt arm & c/o severe pain rt shoulder, neck & back; pt obviously in pain; c/o nausea; afebrile; unable to abduct; visible muscle spams; pt given Medrol, Xavax;
Sun 10/07/2012 day 3 fatigue, muscle aches. Mon 10/08/2012 day 4 headache, chills, extreme fatigue, weakness, muscle aches, 100.9 F temp. Tues 10/09/2012 day 5 fatigue, muscle aches, 100.9 temp. Wed 10/10/2012 day 6 dry cough, HA, fatigue. Thur 10/11/2012 day 7 dry cough, HA, fatigue, slight runny nose. Fri 10/12/2012 day 8 dry cough, fatigue, slight runny nose. Sat 10/13/2012 day 9 fatigue, dry cough, neck pain (probably from coughing all the time). Sun 10/14/2012 day 10 vomiting, neck pain, dry cough, extreme fatigue. Mon 10/15/2012 day 11 fatigue, beginning of cough productive of yellow sputum. Tues 10/16/2012 day 12 frequent coughing productive of yellow sputum, sore throat, fatigue. Wed 10/17/2012 day 13 frequent coughing productive of yellow sputum, sore throat, fatigue. Thur 10/18/2012 day 14 frequent coughing productive of yellow sputum, sore throat, fatigue. Fri 10/19/2012 day 15 lingering frequent cough productive of yellow sputum, resolving fatigue. I suppose this is an "FYI" Report, as it doesn't constitute an "adverse" or serious reaction, however, I must say I have been completely startled and angered by this ongoing cascade of symptoms, I missed 1 1/2 days of work, and have been functioning at 50% on all of the other days. Of course, one cannot conclude that FLUMIST caused all or any of these symptoms. I have not sought treatment by a healthcare provider, as it would be pointless, and have employed numerous home remedies/over the counter treatments to try to deal with symptoms. As far as my own personal opinion about it, I will never opt for FLUMIST again, nor recommend it to any adults that I know personally. As I am an Immunization Nurse at Health Dept., it will not bias the information I give to our clients, which is the information on the VIS.
Vaccine 9/28/07 Fever 104 deg with body aches and left arm pain night of injection, Patient went to ER the next morning-Tx ice and Tylenol
Headache; Brain fog; Dizziness; Vertigo; Loss of balance; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 14Apr2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included thyroid (ARMOUR THYROID), vitamin d nos (VITAMIN D) and magnesium (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. On 22Apr2021, the patient experienced headache, brain fog, dizziness, vertigo, loss of balance and nausea. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, brain fog, dizziness, vertigo, loss of balance and nausea were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Patient felt lightheaded and dizzy.  B/P 74/34 HR 92 RR 20   Water provide Legs elevated.  B/P after 5 min 138/86  Feeling better
G47.33 ADULT OBSTRUCTIVE SLEEP APNEA 2/9/2023 CHOLECYSTITIS
Immediately I had a taste in my mouth I did not have with first vaccine and I felt very strange. Almost like will I pass out? I reported to firefighter he said I was most likely anxious. I drove home and felt different all the way. just kept taking deep breathes. At home about 5:30 ish I started feeling better I had been drinking a lot of water then I realized my left side of my face felt odd.  My eye and Cheek felt numb/swollen I looked in the mirror it did not appear swollen.  Just felt that way. I went to bed at 8:30 woke several times in the night but this morning I can feel a tiny bit in my cheek eye area. nothing like last night. My arm is a little sore but I feel fine.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 29-SEP-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd flu vax & while nurse was removing the needle from pt's arm pt became weak, dizzy & sweaty; when MD saw pt was stiff, but relaxed immed afterward; MD noted sl deviation of the eyes to the rt; pulse thready 80-96bpm & BP 106/76;